All stock reports

RAYMONDREL evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-29T00:55:50.211118+00:00

Metrics

latest_annual_period
2026-03-31
revenue
29775100000.0
net_income
3045900000.0
operating_cash_flow
-9099600000.0
free_cash_flow
-9903200000.0
total_assets
70623800000.0
total_liabilities
54949600000.0
total_equity
15674200000.0
cash
2455000000.0
total_debt
Not supplied
revenue_growth
4.271421995609376
earnings_growth
16.140686550365785
net_margin
0.10229688565277699
roe
0.1943257072131273
debt_to_equity
Not supplied
cash_conversion
-2.9874913818575792
free_cash_flow_margin
-0.3326000584380909
trailing_pe
Not supplied
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

No qualifying opportunity

No candidate at another positional horizon in the coherent source run.

  • No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
Decision ID
decision-c8b70271a87ee177490a234931bb5d7940c195e0b929f08d6509dc564a43e769
Policy
stock-decisions-v1
Evidence bundle hash
f92a5c4b971dce73ad3156fcaaa589a9c632b9cfe04707074f50ebdbaf70cf13
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 2dc6533cfab802c8846197efa744d648fb92b308baeb65995db305b4c8d7402d
  • daily-price: 022bc78ea4885f356edd1a65c8925977188651d1cd7d98efec387fc6fe0c0114
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

The trailing 20-session price return was 28.14%. The cached financial metric revenue growth is 4.271421995609376.

Risks

The trailing 5-session price return was -8.45%. The closing price was -10.28% below its highest close in the available trailing year. Financial data check: weak_cash_conversion: operating cash flow/net income below 0.5. The cached financial metric cash conversion is -2.9874913818575792. The cached financial metric free cash flow margin is -0.3326000584380909.

Follow Up

Price source verification: REPAIRED. Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-29T00:55:50.211118+00:00 from EODHD. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Cached observations and evidence limits